Abbott Laboratories
Abbott Laboratories of Abbott Park, Ill., has announced that its iFS advanced femtosecond laser has received FDA clearance for use in corneal and cataract surgeries to create bow-shaped or curved arcuate incisions. The fifth generation of IntraLase technology, iFS laser is currently used to create lasik flaps and other corneal incisions. The device allows surgeons to make precise, bladeless arcuate incisions during surgery and to customize each incision. “This is an important step as we look to utilize femtosecond laser technology as a potential standard of care during the cataract procedure,” said Jim Mazzo, senior vice president of Abbott Medical Optics Inc., Abbott’s subsidiary in Santa Ana, Calif.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024